Sacrocolpopexy Versus Vaginal Mesh Procedure for Pelvic Prolapse

Francisco Carmona

Status

Unknown

Conditions

Enterocele

Uterine Prolapse

Cystocele

Vaginal Vault Prolapse

Rectocele

Treatments

Device: Sacrocolpopexy

Device: Elevate mesh

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT01097200

Bataller01

Details and patient eligibility

About

Pelvic prolapse is one of the most frequent pathology in Gynecology. Recurrency of the prolapse after primary surgery is relatively high, 15-30%. Sacrocolpopexy has showed to be effective but it requires a long learning curves and is more aggressive. New meshes techniques seem to be effective, as well, with less learning curve but they are expensive and there are no randomize studies published.

The investigators aim is to compare both techniques in terms of: anatomical and functional efficacy, cost, operating time and complications.

Enrollment

60 estimated patients

Sex

Female

Ages

21+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Subject has been diagnosed with one or more clinically significant anterior, apical, or posterior genital prolapse disorder(s)(symptomatic POP-Q stage II or higher) requiring surgical repair.

Exclusion criteria

Investigator determines subject is not a candidate for surgical repair of her genital prolapse.
Subject has had a prior prolapse procedure involving graft placement (synthetic or biologic)
Subject has active or latent systemic infection or signs of tissue necrosis.
Subject has restricted leg motion (inability to abduct or adduct leg positioning in the lithotomy position) with or without a hip replacement / prosthesis.
Subject is currently pregnant or intends to become pregnant during the study period.
Subject has had radiation therapy to the pelvic area.
Subject has pelvic cancer, has had pelvic cancer within the past 12 months or has been on cytostatic medication within the past 12 months.
Subject has uncontrolled diabetes.
Subject is on any medication with could result in compromised immune response, such as immune modulators.
Subject has undergone previous pelvic surgery < 6 months prior to enrollment in this study.
Subject is unwilling or unable to give valid informed consent.
Subject is unwilling or unable to comply with the requirements of the protocol, complete all quality of Life questionnaires and return for all follow-up visits.
Subject with contraindications for laparoscopy